A case of tuberculous arthritis following the use of etanercept

Korean Journal of Internal Medicine

Volumn 24, Issue 4, 2009, Pages 397-401

  Choi, Seung Won ^a   Ahn, Jong Joon ^a   Hwang, Young Tae ^a   Koh, Sang Hoon ^a   Cho, Sung Do ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Arthritis; Osteoarticular; Rheumatoid; Tuberculosis; Tumor necrosis factor alpha

Indexed keywords

ACECLOFENAC; ETANERCEPT; ETHAMBUTOL; ISONIAZID; METHOTREXATE; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; TUBERCULOUS ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUBERCULOSIS, OSTEOARTICULAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 72049107457     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2009.24.4.397     Document Type: Article

References (21)

1. Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic implications. Gastroenterology 2000;119:1148-1157. (Pubitemid 30777934)
2. Algood HM, Lin PL, Flynn JL. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 2005;41(Suppl 3):S189-S193.
3. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 2002;168:4620-4627. (Pubitemid 34441368)
4. Taylor PC. Anti-tumor necrosis factor therapies. Curr Opin Rheumatol 2001;13:164-169.
5. Ellerin T, Rubin RH, Weinblatt ME. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003;48:3013-3022. (Pubitemid 37409310)
6. Hamilton CD. Infectious complications of treatment with biologic agents. Curr Opin Rheumatol 2004;16:393-398. (Pubitemid 38803140)
7. Gardam MA, Keystone EC, Menzies R, et al. Anti-tumor necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003;3:148-155. (Pubitemid 36278124)
8. Seong SS, Choi CB, Woo JH, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 2007;34:706-711. (Pubitemid 46641374)
9. Listing J, Strangfeld A, Kary S, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005;52:3403-3412. (Pubitemid 41612206)
10. Winthrop KL, Siegel JN, Jereb J, Taylor Z, Iademarco MF. Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum 2005;52:2968-2974. (Pubitemid 41447075)
11. Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-1602. (Pubitemid 32162982)
12. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-259. (Pubitemid 29063266)
13. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med 1999;130:478-486. (Pubitemid 29135800)
14. Mohan AK, Cote TR, Block JA, Manadan AM, Siegel JN, Braun MM. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 2004;39:295-299. (Pubitemid 39050474)
15. Gardam M, Lim S. Mycobacterial osteomyelitis and arthritis. Infect Dis Clin North Am 2005;19:819-830.
16. De Backer AI, Mortele KJ, Vanhoenacker FM, Parizel PM. Imaging of extraspinal musculoskeletal tuberculosis. Eur J Radiol 2006;57:119-130.
17. Askling J, Fored CM, Brandt L, et al. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 2005;52:1986-1992. (Pubitemid 40994319)
18. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD; BIOBADASER Group. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003;48:2122-2127. (Pubitemid 36959191)
19. American Thoracic Society (ATS) and Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
20. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005;52:1766-1772. (Pubitemid 40852885)
21. Furst DE, Cush J, Kaufmann S, Siegel J, Kurth R. Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents. Ann Rheum Dis 2002;61(Suppl 2):ii62-ii63.